Navigation Links
Boehringer Ingelheim Announces Interim Results Evaluating Virologic Response Rates in HCV/HIV Co-Infected Patients Treated with Faldaprevir
Date:3/4/2013

treatments for multiple types of patients," said Peter Piliero , MD, vice president, Clinical and Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc. "These new data add to our expanding body of clinical evidence on faldaprevir as we continue to pursue HCV treatment options for a diverse range of patients that physicians frequently encounter in clinical practice."

About STARTVerso™ 4

STARTVerso™ 4 is an open-label, sponsor blinded, Phase 3 study assessing the efficacy and safety of Boehringer Ingelheim's investigational oral protease inhibitor faldaprevir in combination with PegIFN/RBV. The study includes 308 individuals co-infected with HCV and HIV who were treatment-naive (TN) or had relapsed after previous HCV therapy with PegIFN/RBV, and were either HIV treatment-naive or being treated with ART. The trial includes patients with cirrhosis (17% had F4 cirrhosis or Fibroscan >13 kPa).

  • Group 1: 12 or 24 weeks of faldaprevir 240mg once-daily in addition to 24 or 48 weeks of PegIFN/RBV
  • Group 2: 24 weeks of faldaprevir 120mg once-daily in addition to 24 or 48 weeks of PegIFN/RBV

About Boehringer Ingelheim in Hepatitis C Virus (HCV)

In partnership with the scientific community, our clinical trial program, HCVerso™, is rigorously designed to find answers to the challenges that HCV patients face, including those who are the most difficult to treat.

Faldaprevir, also known as BI 201335, is an investigational, oral protease inhibitor that is specifically designed to target viral replication in the liver. The ongoing multi-study Phase 3 STARTVerso™ trial program, evaluating faldaprevir combined with PegIFN/RBV in treatment-naive, treatment-experienced and HIV co-infected patients with chronic genotype-1 HCV, is near clinical completion. BI 207127 is an investigational NS5B non-nucleoside polymerase in
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
2. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
3. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
4. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
5. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
6. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
7. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
8. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
9. Whistleblowers extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
10. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
11. Boehringer Ingelheim Announces Equine Research Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 25, 2014 Reinforcing its commitment to enabling ... PHG AEX: PHIA) today announced 510(k) ... for its IQon Spectral CT , presenting an ... technology adds a new dimension to Computed Tomography (CT) ... characterize structures based on their material content within a ...
(Date:11/26/2014)... -- Unilife Corporation (NASDAQ: UNIS, ASX: UNS), a designer, manufacturer ... that its Chairman and CEO, Alan Shortall , ... Annual Healthcare Conference at the New York Palace Hotel ... The conference presentation will be broadcast ... To listen, please go to: http://ir.unilife.com/events.cfm . An ...
(Date:11/26/2014)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today announced ... upcoming investor conferences.  , 31 st NASDAQ ... December 2, 2014 at 6:45 a.m. EST / 11:45 a.m. GMT. ... International, will provide an overview of the company and a business ... Healthcare Conference in New York, NY on ...
Breaking Medicine Technology:Philips receives FDA 510(k) clearance for IQon Spectral CT 2Philips receives FDA 510(k) clearance for IQon Spectral CT 3Unilife to Present at the Piper Jaffray 26th Annual Healthcare Conference on December 2nd 2Jazz Pharmaceuticals Announces Participation in Two Investor Conferences 2
(Date:11/26/2014)... Baltimore, Maryland (PRWEB) November 26, 2014 ... now accepting submissions for the tenth annual MEDA ... celebrate economic development excellence in Maryland. “The MEDA ... bring economic prosperity to the state. We encourage ... businesses that are making a positive economic impact ...
(Date:11/26/2014)... Francisco, Claifornia (PRWEB) November 26, 2014 ... invasive procedures which include image guided surgeries has ... contrast media injectors. Rising incidence of various types ... to a proportionate increase in demand for these ... The growth of contrast media injectors market can ...
(Date:11/26/2014)... Raleigh, NC (PRWEB) November 26, 2014 ... types of materials science can cause mesothelioma that looks ... just posted a new article on the research. ... at the Fraunhofer Institute for Toxicology and Experimental Medicine ... nanotubes. While all of the rats eventually ...
(Date:11/26/2014)... DC (PRWEB) November 26, 2014 For ... (AIS) independently published The AIS Report on Blue Cross ... and WellPoint, Inc. on the varied strategies the two ... and improve compliance with treatments for sleep apnea, ranging ... sleep disorder, because it’s linked to increased rates of ...
(Date:11/26/2014)... With Thousand Oaks cosmetic dental work ... the Anacapa Dental Art Institute in Woodland Hills and Oxnard, ... for some. , That is why they offer a variety ... “No dentist wants cost to come between a patient and ... Mamaly Reshad, partner in the Anacapa Dental Art Institute. “That’s ...
Breaking Medicine News(10 mins):Health News:Maryland Economic Development Association Seeking Submissions for 2015 Awards 2Health News:Contrast Media Injectors Market To 2020 - Global Industry, Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 2Health News:Contrast Media Injectors Market To 2020 - Global Industry, Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 3Health News:Multi-walled Nanotubes Linked to Mesothelioma in New Study, According to Surviving Mesothelioma 2Health News:AIS Newsletter Reports on Strategies Blues Plans Are Implementing to Combat Sleep Apnea 2Health News:AIS Newsletter Reports on Strategies Blues Plans Are Implementing to Combat Sleep Apnea 3Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 2Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 3Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 4Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 5
... an effort to stem the rise of childhood obesity and ... received a $7.5 million grant to launch a Comprehensive Center ... grant from the National Center on Minority Health and Health ... of Health. , The focus of the center is ...
... being,issued by Rosa Acuna and Harold J. Cassidy: WHAT: Filing ... Jersey Supreme Court as last ... in the historic informed consent abortion,case will be filing a motion ... Jersey Supreme Court in which that court held,that a physician can ...
... Inc.,(Amex: ILE ) announced today that it is ... in Nashville, Tennessee in order to,obtain a quorum of ... Monday, November 5, 2007 at 1:00 p.m. in Philadelphia,Pennsylvania. ... at the meeting,remains the close of business on September ...
... are about 1 in 5,000, research shows , , MONDAY, ... airplane passengers developing serious blood clots in-flight, only about one ... events, a new study finds. , This type of leg ... recent attention. In fact, the condition has been nicknamed "economy ...
... the, Ministry of Health, Kingdom of Swaziland and the Manzini City ... ... Treatment Center, MANZINI, SWAZILAND and LOS ANGELES, Sept. 24 ... Initiative for Community Action on AIDS at the Local,Level) and FLAS (Family ...
... The crews of future,missions to the moon and ... radiation. NASA and the National Space Biomedical Research,Institute, known ... that,will enable NASA to better understand and reduce those ... eight states,will conduct the studies. The goal of ...
Cached Medicine News:Health News:USC receives $7.5M for Comprehensive Center of Excellence in Minority Health 2Health News:Filing for Reconsideration/Press Conference ACUNA v. TURKISH, Historic Informed Consent Abortion Case to the New Jersey Supreme Court 2Health News:Isolagen, Inc. Postpones Annual Meeting 2Health News:In-Flight Clot Risk Low for Most People 2Health News:In-Flight Clot Risk Low for Most People 3Health News:Swaziland: AHF Partners in New Free AIDS Treatment Clinic in Manzini 2Health News:Swaziland: AHF Partners in New Free AIDS Treatment Clinic in Manzini 3Health News:Swaziland: AHF Partners in New Free AIDS Treatment Clinic in Manzini 4Health News:NASA, NSBRI Select 17 Proposals in Space Radiation Research 2
Visionary OFFICE™ PM offers a Windows interface featuring medical billing, appointment scheduling and patient information....
... system allows a practice to manage ... integrated with the EMR, appointment system ... with electronic clearinghouses for electronic claim ... of reports, it presents practice management ...
... The Infinity Amylase CPNG3 single liquid ... the convenience of single liquid stability ... operator error and provide quick result ... the Infinity Amylase CPNG3 reagent provides ...
... Acid single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... Acid reagent provides a long shelf ...
Medicine Products: